Androgenetic alopecia (AGA) is characterized by a non-scarring progressive 
miniaturization of the hair follicle in predisposed men and women with a pattern distribution. 
Although AGA is a very prevalent condition, approved therapeutic options are limited. Objectives:
This work aims to evaluate the role of topical minoxidil in treatment of androgenetic alopecia.
Methods: The study was conducted on 20 patients with androgenetic alopecia. The age of patients 
ranged from 18 to 45 years. Results: Clinical improvement in most of cases which was in the form of 
increase in hair growth and density within affected areas. It started at about 3 months and completed 
by 12 months of treatment. Conclusion: minoxidil is a good alternative for treating AGA in males 
and females.